Literature DB >> 20195575

Interleaved transcranial magnetic stimulation and fMRI suggests that lamotrigine and valproic acid have different effects on corticolimbic activity.

Xingbao Li1, Raffaella Ricci, Charles H Large, Berry Anderson, Ziad Nahas, Daryl E Bohning, Mark S George.   

Abstract

RATIONALE: Combined transcranial magnetic stimulation (TMS) and functional magnetic resonance imaging (fMRI) can be used to study anticonvulsant drugs. A previous study showed that lamotrigine (LTG) inhibited brain activation induced when TMS was applied over motor cortex, whereas it increased activation induced by TMS applied over prefrontal cortex.
OBJECTIVES: The present double-blind, placebo-controlled, crossover study in 30 healthy subjects again combined TMS and fMRI to test whether the effects seen previously with LTG would be confirmed and to compare these with a second anticonvulsant drug, valproic acid (VPA).
RESULTS: Statistical parametric mapping analysis showed that both LTG and VPA, compared to placebo, inhibited TMS-induced activation of the motor cortex. In contrast, when TMS was applied over prefrontal cortex, LTG increased the activation of limbic regions, confirming previous results; VPA had no effect.
CONCLUSION: We conclude that LTG and VPA have similar inhibitory effects on motor circuits, but differing effects on the prefrontal corticolimbic system. The study demonstrates that a combination of TMS and fMRI techniques may be useful in the study of the effects of neuroactive drugs on specific brain circuits.

Entities:  

Mesh:

Substances:

Year:  2010        PMID: 20195575     DOI: 10.1007/s00213-010-1786-y

Source DB:  PubMed          Journal:  Psychopharmacology (Berl)        ISSN: 0033-3158            Impact factor:   4.530


  44 in total

1.  Performance of a system for interleaving transcranial magnetic stimulation with steady-state magnetic resonance imaging.

Authors:  A Shastri; M S George; D E Bohning
Journal:  Electroencephalogr Clin Neurophysiol Suppl       Date:  1999

Review 2.  Prospects for human pharmacological functional magnetic resonance imaging (phMRI).

Authors:  I Tracey
Journal:  J Clin Pharmacol       Date:  2001-07       Impact factor: 3.126

Review 3.  TMS and drugs.

Authors:  Ulf Ziemann
Journal:  Clin Neurophysiol       Date:  2004-08       Impact factor: 3.708

Review 4.  The role of fMRI in drug discovery.

Authors:  Richard G Wise; Irene Tracey
Journal:  J Magn Reson Imaging       Date:  2006-06       Impact factor: 4.813

Review 5.  Antiepileptic drugs in mood-disordered patients.

Authors:  Prashant Gajwani; Anna Forsthoff; David Muzina; Benedikt Amann; Keming Gao; Omar Elhaj; Joseph R Calabrese; Heinz Grunze
Journal:  Epilepsia       Date:  2005       Impact factor: 5.864

6.  A classification of hand preference by association analysis.

Authors:  M Annett
Journal:  Br J Psychol       Date:  1970-08

Review 7.  Stabilization of mood from below versus above baseline in bipolar disorder: a new nomenclature.

Authors:  Terence A Ketter; Joseph R Calabrese
Journal:  J Clin Psychiatry       Date:  2002-02       Impact factor: 4.384

8.  A pooled analysis of 2 placebo-controlled 18-month trials of lamotrigine and lithium maintenance in bipolar I disorder.

Authors:  Guy M Goodwin; Charles L Bowden; Joseph R Calabrese; Heinz Grunze; Siegfried Kasper; Robin White; Paul Greene; Robert Leadbetter
Journal:  J Clin Psychiatry       Date:  2004-03       Impact factor: 4.384

9.  Effects of antiepileptic drugs on motor cortex excitability in humans: a transcranial magnetic stimulation study.

Authors:  U Ziemann; S Lönnecker; B J Steinhoff; W Paulus
Journal:  Ann Neurol       Date:  1996-09       Impact factor: 10.422

Review 10.  Potential mechanisms of action of lamotrigine in the treatment of bipolar disorders.

Authors:  Terence A Ketter; Husseini K Manji; Robert M Post
Journal:  J Clin Psychopharmacol       Date:  2003-10       Impact factor: 3.153

View more
  8 in total

Review 1.  Somatic treatments for mood disorders.

Authors:  Moacyr A Rosa; Sarah H Lisanby
Journal:  Neuropsychopharmacology       Date:  2011-10-05       Impact factor: 7.853

Review 2.  Transcranial magnetic stimulation in the treatment of substance addiction.

Authors:  David A Gorelick; Abraham Zangen; Mark S George
Journal:  Ann N Y Acad Sci       Date:  2014-07-28       Impact factor: 5.691

3.  Repetitive transcranial magnetic stimulation (rTMS) of the dorsolateral prefrontal cortex reduces resting-state insula activity and modulates functional connectivity of the orbitofrontal cortex in cigarette smokers.

Authors:  Xingbao Li; Lian Du; Gregory L Sahlem; Bashar W Badran; Scott Henderson; Mark S George
Journal:  Drug Alcohol Depend       Date:  2017-02-28       Impact factor: 4.492

Review 4.  Concurrent TMS-fMRI: Technical Challenges, Developments, and Overview of Previous Studies.

Authors:  Yuki Mizutani-Tiebel; Martin Tik; Kai-Yen Chang; Frank Padberg; Aldo Soldini; Zane Wilkinson; Cui Ci Voon; Lucia Bulubas; Christian Windischberger; Daniel Keeser
Journal:  Front Psychiatry       Date:  2022-04-21       Impact factor: 5.435

5.  Brain functional and structural characteristics of patients with seizure recurrence following drug withdrawal.

Authors:  Ge Tan; Xiuli Li; Deng Chen; Haijiao Wang; Qiyong Gong; Ling Liu
Journal:  Neuroradiology       Date:  2021-07-01       Impact factor: 2.804

6.  Chronic antiepileptic drug use and functional network efficiency: A functional magnetic resonance imaging study.

Authors:  Tamar M van Veenendaal; Dominique M IJff; Albert P Aldenkamp; Richard H C Lazeron; Paul A M Hofman; Anton J A de Louw; Walter H Backes; Jacobus F A Jansen
Journal:  World J Radiol       Date:  2017-06-28

Review 7.  TMS Does Not Increase BOLD Activity at the Site of Stimulation: A Review of All Concurrent TMS-fMRI Studies.

Authors:  Farshad Rafiei; Dobromir Rahnev
Journal:  eNeuro       Date:  2022-08-18

8.  Imaging the neural mechanisms of TMS neglect-like bias in healthy volunteers with the interleaved TMS/fMRI technique: preliminary evidence.

Authors:  Raffaella Ricci; Adriana Salatino; Xingbao Li; Agnes P Funk; Sarah L Logan; Qiwen Mu; Kevin A Johnson; Daryl E Bohning; Mark S George
Journal:  Front Hum Neurosci       Date:  2012-12-17       Impact factor: 3.169

  8 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.